Cellular Hemoglobin-Based Oxygen Carriers as Potential Artificial Blood Substitutes
The oxygen binding properties of unmodified liposomes encapsulated Hb (ULEHs), PEGylated LEHs (PEG-LEHs) and polymersomes encapsulated Hb (PEHs) were comparable to human RBCs, indicating that these vesicles displayed good potential as cellular HBOCs. The physical integrity of ULEH dispersions in phosphate buffered saline at physiological pH and temperature was unstable post-production, due to osmosis of water into and out of the liposome core, which implies that ULEHs will be osmotically fragile in the blood stream. This potential problem was solved by grafting PEG molecules onto the liposome surface, thereby strengthening the liposome bilayers. However, the Hb encapsulation efficiency of PEG-LEH dispersions was low. The intravascular circulation, biocompatibility and colloidal state of PEG-LEH dispersions were limited due to the limited PEG surface coverage and molecular weight that can be stably conjugated onto the liposome surface.
In contrast, PEH dispersions possessed higher Hb encapsulation efficiencies compared to ULEH, PEG-LEH, PEGylated actin-containing LEH, lipogel particle and nanoscale hydrogel particle dispersions loaded with Hb. Unlike LEH dispersions, encapsulation of Hb into polymersomes did not enhance Hb oxidation. Polymersomes possessed superior PEG shielding ability compared to PEG-liposomes, due to 100% PEG surface coverage with longer PEG brushes. Since polymersomes can be synthesized with thicker hydrophobic membranes compared to liposomes, polymersomes are mechanically stronger than liposomes. Simulation of in-vivo oxygen transport in a capillary and to surrounding tissues, demonstrated that PEH dispersions could be engineered for applications from routine surgery to treatment of trauma. We concluded that PEH dispersions were readily prepared and exhibited good potential as a cellular HBOC, while offering superior physical properties, which may alleviate the limitations encountered with current designs of cellular HBOCs.
History
Date Modified
2017-06-05Defense Date
2005-05-16Research Director(s)
Dr. David LeightonCommittee Members
Dr. David LeightonDegree
- Doctor of Philosophy
Degree Level
- Doctoral Dissertation
Language
- English
Alternate Identifier
etd-05232005-205232Publisher
University of Notre DameAdditional Groups
- Chemical and Biomolecular Engineering
Program Name
- Chemical Engineering